The Turkish Biopharmaceuticals Platform, which was established in 2016 and consists of 24 organizations that already have development or production activities in the field of biotechnology in our country or are planning these activities, continues on its way as the Turkish Biopharmaceuticals Platform. Platform, which will now support studies on vaccines in our country, is preparing to take important steps in the development of the biotechnological pharmaceutical and vaccine industry with its expanding field of activity.
Biotechnological drugs are shaping the future of the world pharmaceutical market. In the last 10 years, biotechnological methods in the world pharmaceutical industry have made it possible to treat many diseases. Therefore, every country is working hard to make biotechnological drugs accessible to patients, and investments in this field are increasing. Pharmaceutical Industry Employers’ Union, one of the leading organizations of the Turkish pharmaceutical industry, also established the Turkish Biopharmaceuticals Platform in 2016 in order to increase the competence and competitiveness of the industry by placing the biotechnological pharmaceutical field among its strategic priorities and to contribute more effectively to the development of this field in our country. Since its establishment, the platform has implemented different projects in close cooperation with both the public and universities. Standing out with the work it has carried out so far, the Platform has decided to expand its field of activity in order to take effective steps in the field of vaccines, the importance of which has been emphasized even more recently, and decided to continue on its way as the Turkish Biopharmaceuticals Platform.
Making a statement on the subject, Murat Barlas, President of the Turkish Biopharmaceuticals Platform, said, “The role of R&D and biotechnology is indisputable so that the Turkish pharmaceutical industry can make the breakthrough it aims and have its deserved place in global competition. In this context, with our Platform for more than 5 years, the biotechnology climate needed in our country will flourish in terms of legislation, understanding and public-private sector-university cooperation; We are working with determination to rise on solid foundations. With the awareness that our activities make a significant difference, we move forward with increasing enthusiasm. With the Covid-19 pandemic that affected the whole world in 2020, we have clearly seen the importance of vaccine development and production competence for countries. In our country, this process was successfully carried out under the roof of the Covid-19 Turkey Platform, which was generated under the leadership of our Ministry of Industry and Technology. However, through this tough period, we see that we have to develop and produce vaccines as a country in order to combat both the process we are going through and the similar epidemics that may occur in the future. In this context, we have decided to expand the scope of our Platform. From now on, as the Turkish Biopharmaceuticals Platform, we will support the studies on vaccines in our country with great effort, and we will make great efforts to strengthen the coordination and cooperation in this field.”
